Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial nitric oxide synthase (eNOS), also known as NOS3, is an enzyme primarily found in vascular endothelial cells that catalyzes the production of nitric oxide (NO) from L-arginine. NO is a crucial signaling molecule involved in vasodilation, inhibition of platelet aggregation, and maintenance of vascular homeostasis. eNOS dysfunction, often due to decreased expression/activity, cofactor deficiency, or excessive oxidative stress, contributes to the pathogenesis of cardiovascular diseases such as hypertension, atherosclerosis, diabetes mellitus, and heart failure.
Enhances nitric oxide production, reduces oxidative stress
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide synthase, endothelial (eNOS).